The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) profoundly affects the regulatory framework of cosmetics in the United States by establishing new requirements for brand owners and facilities. MoCRA is the first major update in US cosmetic law since 1938, and some provisions, such as facility registration and product listing, apply as of December 29, 2023.
Compliance with new requirements might be challenging for the cosmetic industry. With 35 years of experience in global regulatory affairs, Obelis is the ideal partner to help you master MoCRA.
Are you a producer of cosmetic products distributed in the United States? We have services specifically dedicated to you!
✔ Companies based outside the United States manufacturing or producing cosmetic products (known as facilities under MoCRA) must register their facility with the FDA and have a US Agent to handle communications with the FDA.
You can appoint Obelis USA as your US Agent. We will be the contact point between you and the FDA.
✔ Obelis USA can support you with other MoCRA requirements to avoid additional burdens on your team. In particular, we will:
Don’t let regulatory challenges undermine your business. Contact us to find out about our services.
If you appoint Obelis USA as your US Agent, we will assist you with the above and ensure you meet all regulatory requirements for selling cosmetic products in the United States.
Francesca Santacatterina
Publications department
05.10.2023
The information contained on obelis.net is presented for general information purposes only, without obligation and it has been compiled with the utmost care to ensure it remains up to date. Nevertheless, Obelis Group cannot be held liable for the accuracy and completeness of the information published. Any reliance placed on such information is therefore strictly at the User’s risk.